Traditional management of invasive cervical cancer

Obstetrics and Gynecology Clinics of North America

Volumn 29, Issue 4, 2002, Pages 645-657

  Holtz, David O ^a   Dunton, Charles ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CAPECITABINE; CELECOXIB; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEMCITABINE; IFOSFAMIDE; METHOTREXATE; PACLITAXEL; TOPOTECAN;

CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HYSTERECTOMY; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS EXENTERATION; PRIORITY JOURNAL; PROGNOSIS; RACE DIFFERENCE; REVIEW; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; UTERINE CERVICAL NEOPLASMS;

EID: 0036928633     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(02)00023-2     Document Type: Review

References (50)

1. Stehman FB, Perez CA, Kurman RJ, Thigpen JT. Cervical cancer. In: Hoskins JA, Perez CA, Young RC, editors. Principles and Practice of Gynecologic Oncology. 3rd Edition. Philadelphia, PA: Lippincott-Raven; 2001. p. 841-968.
2. Martin LM, Parker SL, Wingo PA, Heath Jr CW. Cervical cancer incidence in screening: Status report on women in the United States, Cancer Pract 1996;4:130-4.
3. Zreik TG, Chambers JT, Chambers SK. Parametrial involvement, regardless of nodal status: A poor prognostic factor for cervical cancer. Obstet Gynecol 1996;87:741-6.
4. Delgado G, Bundy B, Zaino R, et al. Prospective surgical - Pathological study of disease free interval in patients with Stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
5. Tanaka Y, Sawada S, Murata T. Relationship between lymph node metastases and prognosis in patients irradiated postoperatively for carcinoma of the uterine cervix. Acta Radiol 1984;23:455-9.
6. Saigo PE, Cain JM, Kim WS, et al, Prognostic factors in adenocarcinoma of the uterine cervix. Cancer 1986;57:1584-93.
7. Sevin BU, Bloch DA, Nadji M, et al. Surgically defined prognostic parameters in patients with early cervical carcinoma. A multivariate survival tree analysis. Cancer 1996;78:1438-46.
8. Howel EA, Chen YT, Concato J. Differences in cervical cancer mortality among black and white women. Obstet Gynecol 1999;94:509-15.
9. Maiman M, Fuchter RG, Guy L, et al. Human immunodeficiency virus infection and invasive cervical carcinoma. Cancer 1993;71:402-6.
10. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol Oncol 2000;77:460-3.
11. Herzog TJ, Williams S, Adler LM, et al. Potential of cervical electrosurgical excision procedure for the diagnosis and treatment of cervical intraepithelial neoplasm. Gyn Oncol 1999;57:286-93.
12. Schmidt C, Pretorius RG, Bonin M, et al. Invasive cervical cancer following cryotherapy for cervical intraepithelial neoplasia or human papillomavirus infection. Obstet Gynecol 1992;80:797-800.
13. Jakus S, Edmonds P, Dunton CJ, King SA. Margin status and excision of cervical intraepithelial neoplasia: A review. Obstet Gynecol Surv 2000;55:520-7.
14. Collins HS, Burke TW, Woodward JE, et al. Widespread lymph node metastases in a patient with microinvasive cervical carcinoma. Gynecol Oncol 1989;34:219-21.
15. Morris M. Management of stage IA cervical carcinoma. J Nat Cancer Inst Monographs 1996;21:47-52.
16. Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer. Lancet 1997;350:535-40.
17. Morley GW, Seski JC. Radical pelvic surgery versus radiation therapy for Stage I carcinoma of the cervix (exclusive of microinvasion). Am J Obstet Gynecol 1976;126:785-98.
18. Anderson B, LaPolla J, Turner D, Chapman G, Buller R. Ovarian transposition in cervical cancer. Gynecologic Oncology 1993;49:206-14.
19. Gallion HH, van Nagell Jr JR, Donaldson ES, et al. Combined radiation therapy and extrafascial hysterectomy in the treatment of stage IB barrel-shaped cervical cancer. Cancer 1985;56:262-5.
20. Kinney WK, Alvarez RD, Reid GC, et al. The value of adjuvant whole pelvis radiation after Wertheim hysterectomy for early stage squamous cell carcinoma of the cervix with pelvic nodal metastases: A matched control study. Gynecol Oncol 1989;34:258-62.
21. Sedlis A, Bundy BN, Rotman MZ, et al. A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: A Gynecologic Oncology Group study. Gynecol Oncol 1999;73:175-6.
22. Eifel P, Jhingran A. Radiation therapy. In: Barakat RR, Bevers MW, Gershenson DM, Hoskins WJ, editors. Handbook of Gynecologic Oncology. London, UK: Martin Dunitz; 2000. p. 73-85.
23. Perez CA, Breaux S, Medock-Jones H, et al. Correlation between radiation dose and tumor recurrence and complications in carcinoma of the uterine cervix: Stages I and IIA. Int J Radiat Oncol Biol Phys 1979;5:373-82.
24. Fletcher GH. Cancer of the uterine cervix. Janeway lecture. Am J Rotengnol Radium Ther Nucl Med 1971;111:225-42.
25. Montana GS, Fowler WC, Varia MA, et al. Carcinoma of the cervix, stage III. Results of radiation therapy. Cancer 1986;57:148-54.
26. Perez CA, Breaux S, Medock-Jones H, et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. I. Analysis of tumor recurrence. Cancer 1983;51:1393-402.
27. Bonomi P, Blessing JA, Stehman FB, et al. A randomized trial of three cisplatin dose schedules in squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. J Clin Oncol 1985;3:1079-85.
28. Keyes HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 1999;340:1154-61.
29. Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999;340:1137-43.
30. Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340:1144-53.
31. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology, 5th Edition. St Louis, MO: Mosby; 1997.
32. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. Cancer 1948;1:177-83.
33. Van Dyke AH, Van Nagell Jr JR. The prognostic significance of ureteral obstruction in patients with recurrent carcinoma of the cervix uteri. Surg Gynecol Obstet 1975;141:371-3.
34. Miller B, Morris M, Rutledge F, et al. Aborted exenterative procedures in recurrent cervical cancer. Gynecol Oncol 1993;50:94-9.
35. Shingleton HM, Soong SJ, Gelder MS, et al. Clinical and histopathological factors predicting recurrence and survival after pelvic exenteration for cancer of the cervix. Obstet Gynecol 1989;73:1027-34.
36. Vergote IB. Exenterative surgery. Curr Opin Obstet Gynecol 1997;9:25-8.
37. Thigpen JT, Blessing JA, DiSaia PJ, et al. A randomized comparison of a rapid versus prolonged (24hr) infusion of cisplatin in therapy of squamous cell carcinoma of the uterine cervix: A Gynecologic Oncology Group study. Gynecol Oncol 1989;32:198-202.
38. Rose PG, Blessing JA, Gershenson DM, McGehee R. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: A Gynecologic Group study. J Clin Oncol 1999;17:2676-80.
39. Serur E, Mathews RP, Gates J, et al. Neoadjuvant chemotherapy in stage 1B2 squamous cell carcinoma of the cervix. Gynecol Oncol 1997;65:348-56.
40. Duenas-Gonzales A, Lopez-Graniel C, Gonzales A, et al. A phase II study of gemcitabine and cisplatin combination as induction chemotherapy for untreated locally advanced cervical carcinoma. Ann Oncol 2001;12:541-7.
41. Eddy GL, Manetta A, Alverez A, et al. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: A Gynecologic Oncology Group pilot study. Gynecol Oncol 1995;57:412-6.
42. Shingleton HM, Bell MC, Fremgen A, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer 1995;76:1948-55.
43. Nieminen P, Kallio M, Hakama M. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of the cervix uteri. Obstet Gynecol 1995;85:1017-21.
44. Liu S, Semenciw R, Mao Y. Cervical cancer: The increase in incidence of adenocarcinoma and adenosquamous cancer in younger women. Can Med Assoc J 2001;1164:1151-2.
45. Eifel EJ, Burke TW, Mooris M, Smith TL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with Stage IB cervical carcinoma. Gynecol Oncol 1995;59:38-44.
46. Quinn FA. Adenocarcinoma of the cervix: Are there arguments for a different treatment policy? Current Opinions in Obstetrics and Gynecology 1997;9:21-4.
47. Chen RJ, Chang DY, Yen ML, et al. Prognostic factor of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 1998;69:157-64.
48. Nguyen C, Montz FJ, Bristow RE. Management of stage I cervical cancer in pregnancy. Obstet Gynecol Surv 2000;55:633-43.
49. Goldberg GL, Altaras MM, Block B. Cone cerclage in pregnancy. Obstet Gyencol 1991;77:315-7.
50. Mitsuhashi A, Sekiya S. Loop electrosurgical excision procedure (LEEP) during first trimester of pregnancy. Int J Gyn Obstet 2000;71:237-9.